This federal contract Indefinite Delivery Vehicle (IDV) was awarded by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs (VA) to RLS USA Inc., a foreign-owned, for-profit radiopharmacy company. The single-award IDV has a ceiling value of $4,998,603.38 and a period of performance through September 17, 2029. It covers the provision of a range of radiopharmaceuticals, including gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate, which are critical for nuclear medicine imaging procedures and diagnostic services provided to veterans and military personnel at VA medical centers and Department of Defense facilities.
Under this IDV, RLS USA Inc. received a $981,644.58 firm-fixed price delivery order contract with a performance period ending on September 17, 2025. The company operates 31 radiopharmacy facilities across the U.S., enabling it to efficiently deliver these time-sensitive radiopharmaceutical products nationwide. RLS USA Inc. also holds several other federal contract IDVs with the VA and Defense Health Agency to facilitate the procurement of its radiopharmaceutical offerings.
Generated 8/13/24, 10:55 AM